Adalta Capital Management’s Eli Lilly LLY Stock Holding History

Adalta Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$928K	Buy	1,009 +183	+22%	+$186K	0.44%	42
2025 Q4	$888K	Buy	826 +123	+17%	+$118K	0.4%	40
2025 Q3	$536K	Buy	703 +198	+39%	+$147K	0.24%	55
2025 Q2	$394K	Sell	505 -5	-1%	-$3.88K	0.2%	57
2025 Q1	$421K	Sell	510 -275	-35%	-$229K	0.22%	56
2024 Q4	$606K	Hold	785	–	–	0.32%	45
2024 Q3	$695K	Sell	785 -600	-43%	-$539K	0.36%	45
2024 Q2	$1.25M	Buy	1,385 +200	+17%	+$160K	0.68%	30
2024 Q1	$922K	Buy	1,185 +175	+17%	+$125K	0.51%	36
2023 Q4	$589K	Buy	1,010 +365	+57%	+$213K	0.36%	45
2023 Q3	$346K	Buy	645 +160	+33%	+$82.4K	0.24%	55
2023 Q2	$227K	Buy	+485	New	+$203K	0.15%	58

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Adalta Capital Management's LLY Position: Q1 2026 in Review

Adalta Capital Management increased its Eli Lilly (LLY) stake by 22% in Q1 2026, buying an estimated $186K and bringing the position to 1,009 shares worth $928K. The position accounts for 0.44% of the portfolio, ranked #42.

Adalta Capital Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.25M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Adalta Capital Management held 1,009 shares of Eli Lilly worth $928K as of Q1 2026.
Adalta Capital Management bought 183 Eli Lilly shares in Q1 2026, an estimated $186K.
Eli Lilly made up 0.44% of Adalta Capital Management's portfolio in Q1 2026, its #42 holding.
Adalta Capital Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
Adalta Capital Management's Eli Lilly position peaked at $1.25M in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Adalta Capital Management's 13F filing for Q1 2026, filed 18 May 2026.